Intrinsic Value of S&P & Nasdaq Contact Us

Werewolf Therapeutics, Inc. HOWL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.00
+9%

Stock Statistics — HOWL

Werewolf Therapeutics, Inc. (HOWL) has a market capitalization of $44.59M and trades at $0.92. The 52-week range is 0.53-2.38.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.7, Earnings Per Share (EPS) of $-1.32.

The stock has a beta of 0.54, operates in the Healthcare sector.

Trading Data
Current Price$0.92
52-Week Range0.53-2.38
Volume110.46K
Avg Volume (30D)436.46K
Market Cap$44.59M
Beta (1Y)0.54
Company
IPO Date2021-04-30
Employees46
CEOMichael Urban
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS95075A1079
CUSIP95075A107
Income (Latest Year)
Gross Profit$-1.63M
EBITDA$-59.04M
Operating Income$-60.68M
Net Income$-60.82M
EPS$-1.32
EPS Diluted$-1.33
Shares Outstanding$46.02M
Balance Sheet (Latest Year)
Total Assets$69.4M
Current Assets$58.59M
Cash & ST Investments$57.95M
Total Liabilities$44.59M
Total Debt$9.44M
Net Debt$-48.52M
Total Equity$24.81M
Debt / Equity0.38
Valuation Ratios
P/E Ratio-0.7
P/B Ratio1.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message